Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Obsidian Therapeutics (NASDAQ:OBX) through any online brokerage.
Other companies in Obsidian Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Obsidian Therapeutics has a consensus price target of $42.00.
The stock price for Obsidian Therapeutics (NASDAQ: OBX) is $37.7 last updated August 11, 2026 at 9:29 AM EDT.
There are no upcoming dividends for Obsidian Therapeutics.
Obsidian Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Obsidian Therapeutics.
Obsidian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.